section name header

Basics

Basics

Overview

  • Failure of autonomic function in multiple organs with minimal motor or sensory involvement.
  • Young adult, rural, Midwestern dogs at greatest risk.
  • Treatment is symptomatic and the prognosis guarded.

Signalment

  • Dog and less commonly cat.
  • No breed or sex predilection.
  • Median age is 18 months but any age animal may be affected.

Signs

  • Acute to subacute onset (5–14 days).
  • Various combinations of signs may be present but both sympathetic and parasympathetic signs in various organs are necessary to be confident of a diagnosis.
  • Sensory or motor deficits are minimal.

Presenting Complaints

  • Most commonly GI signs of vomiting or regurgitation, diarrhea, or occasionally constipation.
  • Straining to urinate and dribbling urine.
  • Photophobia and third-eyelid elevation.
  • Dyspnea, coughing, and purulent nasal discharge.
  • Depression, anorexia, and weight loss.

Examination Findings

  • Variable combinations of autonomic dysfunction.
  • Loss of anal sphincter tone.
  • Dry nose and mucous membranes; lack of tear production.
  • Distended, easily expressed bladder.
  • Pupils midrange to maximally dilated with no pupillary light reflex but intact vision.
  • Third-eyelid elevation, ptosis, and enophthalmos.
  • Lack of gut sounds and occasional abdominal pain.
  • Heart rate and blood pressure typically in the low end of normal range but do not rise in response to stress.
  • Secondary aspiration pneumonia or rhinitis.
  • Cachexia.
  • Occasionally mild proprioceptive deficits or weakness.

Causes & Risk Factors

  • Cause unknown.
  • Highest incidence in Missouri, Oklahoma, and Kansas as well as Wyoming and northern Colorado, but occasional cases reported throughout United States.
  • Free-roaming, rural dogs at greatest risk.

Diagnosis

Diagnosis

Differential Diagnosis

  • Anticholinergic toxicity.
  • Other differential diagnoses depend upon the specific clinical signs; e.g., urinary tract infection for dysuria, corneal ulcer for photophobia, dehydration for dry mucous membranes.

CBC/Biochemistry/Urinalysis

Unremarkable

Imaging

  • Megaesophagus ± aspiration pneumonia
  • Distended bowel loops with no peristalsis
  • Distended urinary bladder
  • Echocardiography may show systolic dysfunction as a reduced fractional shortening.

Diagnostic Procedures

  • If pupils affected, 0.05% pilocarpine drops in one eye will produce miosis within 60 minutes. Rules out anticholinergic toxicity.
  • Atropine (0.03 mg/kg IV) may not produce a rise in heart rate; suggests loss of vagal tone.
  • Intradermal histamine may produce no response or a wheal but no flare; demonstrates loss of sympathetic innervation of arterioles.

Treatment

Treatment

Medications

Medications

Drug(s)

  • Antibiotics as needed to treat secondary infections.
  • Prokinetic drug such as metoclopramide if GI motility affected.
  • Bethanechol to stimulate lacrimation and urination (start at 0.05 mg/kg q8–12h and adjust dose based on response); manual expression of bladder more reliable.
  • Ocular pilocarpine to relieve photophobia.
  • Pimobendan if poor cardiac contractility.

Contraindications/Possible Interactions

  • Animals with dysautonomia develop denervation supersensitivity to direct acting cholinergic or adrenergic drugs.
  • Great care must be exercised in using such drugs, particularly adrenergic drugs that could precipitate fatal tachyarrhythmias. It is best to start at <10% of the low end of the dose range when using direct-acting drugs and escalate the dose as needed to produce the desired effect.

Follow-Up

Follow-Up

Miscellaneous

Miscellaneous

Abbreviation

  • GI = gastrointestinal

Author Dennis P. O'Brien

Consulting Editor Joane M. Parent

Suggested Reading

Berghaus RD, O'Brien DP, Johnson GC, Thorne JG. Risk factors for development of dysautonomia in dogs. J Am Vet Med Assoc 2001, 218:12851292.

Harkin KR, Andrews GA, Nietfeld JC. Dysautonomia in dogs: 65 cases (1993–2000). J Am Vet Med Assoc 2002, 220:633644.

Harkin KR, Bulmer BJ, Biller DS. Echocardiographic evaluation of dogs with dysautonomia. J Am Vet Med Assoc 2009, 235:14311436.

Kidder AC, Johannes C, O'Brien DP, Harkin KR, Schermerhorn T. Feline dysautonomia in the Midwestern United States: a retrospective study of nine cases. J Fel Med Surg 2008, 10:130136.

Longshore RC, O'Brien DP, Johnson GC, et al. Dysautonomia in dogs-a retrospective study. J Vet Intern Med 1996, 10(3):103109.

O'Brien DP, Johnson GC. Dysautonomia and autonomic neuropathies. Vet Clin North Am Small Anim Pract 2002, 32:251265.